The company has won a series of national awards and grants, such as the third "Chunhui Cup" of the Ministry of education, China overseas students innovation and Entrepreneurship Competition Award, China Science and technology entrepreneurship competition new seedling award, gold seed Entrepreneurship Competition Award, 2013 China overseas students entrepreneurship 100 enterprises most entrepreneurial potential award, 2016 demonhealth sea final first prize and so on. At present, we have successfully developed the third generation of technology circulation tumor living cell capture instrument, matching gene detection kit, full-automatic fish fluorescence scanner, lung cancer, colon cancer and other early cancer gene detection kits and other products, and established the technical platform of tumor liquid biopsy (including ctDNA, CTC, exosomes), single cell sequencing, personalized drug testing, etc. The company will continue to adhere to the business philosophy of "innovative technology, leading the future", and strive to grow into a leader in the development of innovative medical products, aiming to achieve breakthroughs in the field of early diagnosis and targeted treatment of tumors, and benefit human life and health.
Leave us a message?
If you have any questions or want to know about the product, please let us know in time